Epidemiological evolution of COVID-19 in Brazil and worldwide
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/4653 |
Resumo: | Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19. |
id |
UNIFEI_5bd7b9e995df85e23cf44a43e877d9c7 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/4653 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Epidemiological evolution of COVID-19 in Brazil and worldwideEvolución epidemiológica de COVID-19 en Brasil y en todo el mundoEvolução epidemiológica da COVID-19 no Brasil e no mundoCoronavírusPandemiaEpidemiologiaMortalidade.CoronavirusPandemiaEpidemiologíaMortalidad.CoronavirusPandemicEpidemiologyMortality.Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.Objetivo: analizar la evolución epidemiológica de COVID-19 en Brasil en correlación con el escenario mundial actual. Metodología: este es un estudio epidemiológico analítico y documental con un enfoque cuantitativo y descriptivo de datos secundarios del COVID-19 del Boletín Epidemiológico Especial número 15 del Ministerio de Salud de Brasil sobre la situación epidemiológica hasta el 8 de mayo de 2020. Resultados: Estados Unidos lidera en número de casos confirmados 1.318.787 (33%) y muertes 78.503 (28%) en el mundo. Brasil, ocupa el octavo lugar con 145,328 (4%) de los casos confirmados de COVID-19, su letalidad es de 6.8% y la mortalidad es de 46.6 por 1,000,000 de habitantes. En 2020, se registraron 107.895 hospitalizaciones por síndrome respiratorio agudo severo en Brasil, de las cuales 27.086 (25%) fueron casos confirmados de COVID-19 y 7.514 (28%) murieron, con personas de 60 años o más 5.697 (69%) de los casos y enfermedades cardíacas y diabetes fueron los grupos de riesgo que se destacaron considerablemente en las muertes de ancianos. Conclusión: la enfermedad aún no está bajo control, la distancia social y el uso de máscaras son la mejor manera de prevenir la progresión de casos y muertes por COVID-19.Objetivo: analisar a evolução epidemiológica da COVID-19 no Brasil correlacionando ao cenário mundial atual. Metodologia: trata-se de um estudo epidemiológico analítico e documental com abordagem quantitativa e descritiva de dados secundários da COVID-19 do Boletim Epidemiológico Especial número 15 do Ministério da Saúde do Brasil sobre a situação epidemiológica até o dia 08 de maio de 2020. Resultados: os Estados Unidos lideram em número de casos confirmados 1.318.787 (33%) e óbitos 78.503 (28%) no mundo. O Brasil, ocupa o 8º lugar com 145.328 (4%) dos casos confirmados de COVID-19, a sua letalidade está em 6,8% e a mortalidade é de 46,6 por 1.000.000 de habitantes. Em 2020, registrou-se 107.895 hospitalizações por Síndrome Respiratória Aguda Grave no Brasil, desse total, 27.086 (25%) eram casos confirmados de COVID-19 e 7.514 (28%) evoluíram para óbito, sendo as pessoas com 60 anos ou mais 5.697 (69%) dos casos e as cardiopatias e o diabetes os grupos de risco que destacaram-se consideravelmente nos óbitos dos idosos. Conclusão: a doença ainda não está sob controle, o distanciamento social e o uso de máscaras são a melhor forma de evitar a progressão de casos e mortes por COVID-19.Research, Society and Development2020-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/465310.33448/rsd-v9i7.4653Research, Society and Development; Vol. 9 No. 7; e630974653Research, Society and Development; Vol. 9 Núm. 7; e630974653Research, Society and Development; v. 9 n. 7; e6309746532525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4653/4022Copyright (c) 2020 Gabriel Mauriz de Moura Rocha, Aldenora Maria Ximenes Rodrigues, Bruno Nascimento Sales, Grasyele Oliveira Sousa, Guilherme Antônio Lopes de Oliveirainfo:eu-repo/semantics/openAccessSousa, Grasyele OliveiraSales, Bruno NascimentoRodrigues, Aldenora Maria XimenesRocha, Gabriel Mauriz de MouraOliveira, Guilherme Antônio Lopes de2020-08-20T18:05:03Zoai:ojs.pkp.sfu.ca:article/4653Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:26.086822Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Epidemiological evolution of COVID-19 in Brazil and worldwide Evolución epidemiológica de COVID-19 en Brasil y en todo el mundo Evolução epidemiológica da COVID-19 no Brasil e no mundo |
title |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
spellingShingle |
Epidemiological evolution of COVID-19 in Brazil and worldwide Sousa, Grasyele Oliveira Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
title_short |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_full |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_fullStr |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_full_unstemmed |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_sort |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
author |
Sousa, Grasyele Oliveira |
author_facet |
Sousa, Grasyele Oliveira Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
author_role |
author |
author2 |
Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Sousa, Grasyele Oliveira Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
dc.subject.por.fl_str_mv |
Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
topic |
Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
description |
Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-05-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4653 10.33448/rsd-v9i7.4653 |
url |
https://rsdjournal.org/index.php/rsd/article/view/4653 |
identifier_str_mv |
10.33448/rsd-v9i7.4653 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4653/4022 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 7; e630974653 Research, Society and Development; Vol. 9 Núm. 7; e630974653 Research, Society and Development; v. 9 n. 7; e630974653 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052650613637120 |